SecSonar.com

Femasys Inc. (FEMY)

Femasys Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Femasys Inc. (FEMY) is a Medical - Instruments & Supplies company based in US with a market capitalization of $11.1M. Revenue grew 40.8% year-over-year and free cash flow was negative at -$19.2M. This page tracks FEMY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 69 employees · IPO Jun 18, 2021

Valuation

Valuation & price

$0.36 · as of May 17, 2026 · -98.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.88

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$20.80$12.23$3.67Jul 25Dec 25Jul 26Jul 7, 25$18.59Jul 9, 25$19.40Jul 11, 25$18.50Jul 15, 25$18.65Jul 17, 25$18.74Jul 21, 25$17.64Jul 23, 25$17.54Jul 25, 25$18.00Jul 29, 25$16.76Jul 31, 25$16.58Aug 4, 25$16.17Aug 6, 25$18.64Aug 11, 25$15.51Aug 13, 25$15.33Aug 15, 25$14.20Aug 19, 25$13.42Aug 21, 25$11.35Aug 25, 25$10.30Aug 27, 25$7.21Aug 29, 25$7.10Sep 3, 25$7.40Sep 5, 25$7.52Sep 9, 25$7.48Sep 11, 25$7.34Sep 16, 25$7.40Sep 18, 25$7.20Sep 22, 25$7.23Sep 24, 25$7.07Sep 26, 25$7.20Sep 30, 25$7.05Oct 2, 25$8.30Oct 6, 25$16.78Oct 8, 25$11.94Oct 10, 25$12.25Oct 14, 25$11.79Oct 16, 25$14.91Oct 21, 25$12.77Oct 23, 25$12.17Oct 27, 25$14.18Oct 29, 25$12.59Oct 31, 25$12.74Nov 4, 25$13.67Nov 6, 25$15.62Nov 10, 25$20.80Nov 12, 25$19.25Nov 14, 25$17.95Nov 18, 25$14.40Nov 20, 25$16.01Nov 25, 25$19.81Nov 28, 25$20.20Dec 2, 25$17.80Dec 4, 25$18.00Dec 8, 25$16.35Dec 10, 25$17.25Dec 12, 25$17.13Dec 16, 25$17.07Dec 18, 25$15.95Dec 22, 25$15.92Dec 24, 25$14.56Dec 29, 25$12.09Jan 2, 26$12.73Jan 6, 26$11.90Jan 8, 26$11.81Jan 12, 26$11.90Jan 14, 26$13.80Jan 16, 26$13.01Jan 21, 26$12.79Jan 23, 26$12.51Jan 27, 26$11.90Jan 29, 26$10.97Feb 2, 26$10.32Feb 4, 26$10.80Feb 9, 26$10.62Feb 11, 26$10.09Feb 13, 26$10.16Feb 18, 26$10.57Feb 20, 26$10.83Feb 24, 26$10.90Feb 26, 26$11.17Mar 2, 26$10.76Mar 4, 26$10.91Mar 6, 26$10.60Mar 10, 26$10.72Mar 12, 26$11.00Mar 17, 26$11.60Mar 19, 26$11.57Mar 23, 26$10.47Mar 25, 26$10.26Mar 27, 26$9.65Mar 31, 26$8.40Apr 2, 26$8.78Apr 7, 26$7.85Apr 9, 26$7.90Apr 13, 26$8.02Apr 15, 26$8.58Apr 17, 26$8.48Apr 22, 26$8.20Apr 24, 26$8.14Apr 28, 26$7.46Apr 30, 26$7.30May 4, 26$7.44May 6, 26$9.06May 8, 26$8.60May 12, 26$7.54May 14, 26$7.61May 18, 26$7.26May 20, 26$7.02May 22, 26$8.76May 28, 26$7.59Jun 1, 26$7.56Jun 3, 26$7.36Jun 5, 26$6.13Jun 9, 26$5.25Jun 11, 26$4.78Jun 15, 26$3.98Jun 17, 26$4.19Jun 22, 26$4.08Jun 24, 26$3.67Jun 26, 26$3.80Jul 2, 26$4.17
$3.6052-week range$20.80
Loading valuation history…

Fundamentals

Key fundamentals

$11.1M

Market cap

40.8%

Revenue growth (YoY)

62.0%

Gross margin

-$19.2M

Free cash flow (USD)

-$4.6M

Net debt

Net cash position

77.6%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$929.1KFY 2020$1.0MFY 2021$1.2MFY 2022$1.2MFY 2023$1.1MFY 2024$1.6MFY 2025$2.3M
$929.1K$2.3M

Free cash flow by year

2019 → 2025

FY 2019$-11.7MFY 2020$-5.0MFY 2021$-8.2MFY 2022$-11.1MFY 2023$-11.4MFY 2024$-20.2MFY 2025$-19.2M
-$11.7M-$19.2M

Gross margin by year

2021 → 2025

FY 202168.6%FY 202263.4%FY 202364.5%FY 202466.5%FY 202562.0%
68.6%62.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 24, 2026Filing
  • 8-K eventRegained Nasdaq ComplianceJun 24, 2026Filing
  • 8-K eventReverse Stock SplitJun 5, 2026Filing
  • 8-K eventReverse Stock SplitJun 4, 2026Filing
  • 8-K eventCorporate PresentationMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 8, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventStockholder Meeting ResultsApr 29, 2026Filing
  • 8-K eventExecutive Employment AgreementApr 1, 2026Filing

Questions

Frequently asked questions

What is Femasys Inc.'s market cap?

Femasys Inc. (FEMY) has a market capitalization of $11.1M.

What is FEMY's P/E ratio?

A meaningful P/E ratio is not available for FEMY — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is FEMY's price-to-book (P/B) ratio?

FEMY trades at 1.88 times book value per share.

Are insiders buying FEMY stock?

SEC Form 4 filings show no open-market insider buys at Femasys Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

NXGL

NEXGEL, Inc.

$5.6M

ZJYL

Jin Medical International Ltd.

$17.6M

LUCY

Innovative Eyewear, Inc.

$4.1M

RVP

Retractable Technologies, Inc.

$20.4M

HBIO

Harvard Bioscience, Inc.

$26.7M

MLSS

Milestone Scientific Inc.

$33.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.